Platelet‐Activating Factor Produced by Endothelial Cells: A Molecule with Autocrine and Paracrine Properties

European Journal of Biochemistry

Volumn 229, Issue 2, 1995, Pages 327-337

  Bussolino, Federico ^a   Camussi, Giovanni ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

angiogenesis; cytokines; endothelial cells; Platelet activating factor; proteases

Indexed keywords

ELASTASE; PHOSPHATE ACETYLTRANSFERASE; PHOSPHOLIPASE A2; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

CELL ADHESION; CYTOCHEMISTRY; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; REVIEW;

CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM; HEPARITIN SULFATE; HUMAN; P-SELECTIN; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 85047692995     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1995.tb20472.x     Document Type: Review

References (117)

1. Effect of platelet activating factor (PAF) on the formation of blood vessels in subcutaneous implants in mice
2. Choline‐linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutro‐phils
3. 2 and acetyltransferase activities during phagocytosis and ionophore stimulation
4. Activation of l‐alkyl‐2‐lysoglycerol‐3‐phosphocholine. Acetyl‐CoA transferase during phagocytosis in human polymorphonuclear leukocytes
5. Evidence for protein‐catalyzed transfer of platelet activating factor by macrophage cytosol
6. Leukocyte‐dependent histamine release from rabbit platelets. The role of IgE, basophils, and platelet‐activating factor
7. PAF activation of a voltage‐gated R‐type Ca2+ channel in human and canine aortic endothelial cells
8. A specific acetylhydrolase for l‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine (a hypotensive and platelet activating lipid
9. Perspectives in platelet‐activating factor research
10. Interleu‐kin‐1 induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet activating factor
11. The mechanism of internalization of platelet‐activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane
12. Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells
13. Alkyl‐ether phosphoglycerides influence calcium fluxes into human endothelial cells
14. Production of platelet activating factor by chick retina
15. Interleukin‐1 stimulates platelet activating factor production in human endothelial cells
16. Studies on the mechanism of interleukin‐1 stimulation of platelet activating factor synthesis in human endothelial cells in culture
17. EC are targets for platelet activating factor. I. Platelet activating factor induces changes in cytoskeleton structure
18. Synthesis and release of platelet activating factor by human vascular endothelial cells treated with tumor necrosis factor and interleukin‐1
19. Selected cytokines promote the synthesis of platelet activating factor in vascular endothelial cells: comparison between tumor necrosis factor and interleukin‐1
20. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines
21. Role of platelet activating factor in the adhesion process of polymorphonuclear neurophils to endothelial cells
22. Involvement of a serine protease in the synthesis of platelet‐activating factor by endothelial cells stimulated by IL‐1α or TNFα
23. Human endothelial cells are target for platelet activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF
24. Leukocyte‐endothelial cells recognition: Three (or more) steps to specificity and diversity
25. The release of platelet activating factor from human endothelial cells in culture
26. Release of platelet activating factor in rabbits with antibody‐mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells
27. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet activating factor
28. Synthesis and release of platelet activating factor is inhibited by plasma al proteinase inhibitor or al antichymotripsin and is stimulated by pro‐teinases
29. Antiinflam‐matory peptides (antiinflammins) inhibit synthesis of platelet activating factor, neutrophil aggregation and chemotaxis and intradermal inflammatory reactions
30. Hypoxia increases stimulus‐induced PAF production and release from human umbilical vein endothelial cells
31. Platelet‐activating factor: receptors and signal transduction
32. Biosynthesis of platelet activating factor and 1‐O‐acyl analogues by endothelial cells
33. Biosynthesis of platelet‐activating factor in cultured mast cells. Involvement of the CoA‐independent transacylase demonstrated by analysis of the molecular species of platelet‐activating factor
34. Modulation of endothelial functions by different molecular species of interleukin‐1
35. PAF‐acether‐induced synthesis of prostacyclin by human endothelial cells
36. Differential effects of tumor necrosis factor‐alpha and platelet‐activating factor on bovine pulmonary artery endothelial cells in vitro
37. Preliminary studies of an acid‐labile factor (ALF) in human sera that inactivates platelet‐activating factor (PAF)
38. Angiogenesis
39. + exchange in thrombin‐induced platelet‐activating factor production by human endothelial cells
40. Platelet activating factor effects on bovine pulmonary artery endothelial cells
41. Identification of platelet‐activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine
42. Effect of platelet activating factor on endothelial permeability to macromolecules
43. Stimulation of platelet activating factor synthesis in human endothelial cells by activation of the de novo pathway. Phorbol 12‐myristate 13‐acetate activates l‐alkyl‐2‐lyso‐sn ‐glycero‐3‐phosphate: acetyl‐CoA acetyltransferase and dithiothreitol insensitive 1‐alkyl‐2‐acetyl‐sn‐glycerol: CDP‐choline cholinephos‐photransferase
44. Protein kinase C and cyclic AMP modulate thrombin‐induced platelet activating factor synthesis in human endothelial cells
45. Human endotheliai cells are target for platelet activating factor. II. Platelet‐activating factor induces platelet‐activating factor synthesis in human umbilical vein endothelial cells
46. Nitrovasodilators inhibit thrombin‐induced platelet‐activating factor synthesis in human endothelial cells
47. Release of vasoactive amines from rabbit platelets induced by antiplatelet antibody in the presence and absence of complement
48. Endothelial cells‐associated platelet activating factor primes neutrophils for enhanced superoxide production and rachidonic acid release during adhesion to but not transmigration across IL‐1β‐treated endothelial monolayers
49. Regulation of PAF‐acether (platelet‐activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin
50. Activation of the acetyl‐coenzyme A: lysoplatelet‐activating factor acetyltransferase regulates platelet activating factor synthesis in human endothelial cells
51. Cloning by functional expression of platelet activating factor receptor from guinea pig lung
52. Biosynthesis of paf‐acether (platelet‐activating factor). VII. Precursors of paf‐acether and acetyltransferase activity in human leukocytes
53. Interaction of antagonist WEB2086 and its He‐trazepine analogue with human platelets and endothelial cells
54. Role of endothelial leukocyte adhesion molecule‐1 and platelet‐activating factor in neutrophil adherence to IL‐1 prestim‐ulated endothelial cells. Endothelial leukocyte adhesion molecule‐1‐mediated CD18 activation
55. Neutrophil migration across monolayers of cytokine‐prestimulated endothelial cells: a role for platelet‐activating factor and IL‐8
56. The human leukocyte platelet‐activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope‐bearing analog
57. Immune regulation by platelet‐activating factor: II. Mediation of suppression by cytokine‐stimulated endothelial cells in vitro
58. Substrate specificity in the biocleavage of the‐alkyl bond: l‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine (a hypotensive and platelet‐activating lipid) and its metabolites
59. Increased biosynthesis of platelet activating factor in activated human eosinophils
60. A de novo pathway for the formation of 1‐alkyl‐2‐acetyl‐sn ‐glycerols, precursors of platelet activating factor. Biochemical characterisation of l‐alkyl‐2‐lyso‐sn ‐glycero‐3‐P: acetylCoA acetyltransferase in rat spleen
61. Formation of l‐alkyl‐2‐acetyl‐sn ‐glycerols via the de novo biosynthetic pathway for platelet activating factor. Characterization of l‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphate phosphohydrolase in rat spleens
62. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils
63. Hydrogen peroxide stimulates the synthesis of platelet‐activating factor by endothelium and induces endothelial cell‐dependent neutrophil adhesion
64. Inflammatory roles of P‐selectin
65. Cytokine regulation of endothelial cell function
66. Distinct platelet‐activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
67. Cultured endothelial cells synthesize both platelet‐activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate
68. Leukocytes C4 and D4 stimulate human endothelial cells to synthesize platelet‐activating factor and bind neutrophils
69. PAF molecular heterogeneity: Pathobiological Impilcations
70. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF
71. Effects of arachidonic acid metabolites and interleukin‐1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice
72. Streptokinase induces intravascular release of platelet‐activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells
73. Tumor‐necrosis factor a‐induced angiogenesis depends on ‘in situ’ platelet activating factor biosynthesis
74. The molecular species distribution of platelet‐activating factor synthesized by rabbit and human neutrophils
75. Biosynthesis of platelet‐activating factor. I. Evidence for an acetyl‐transferase activity in murine macrophages
76. Biosynthesis of paf‐acether. XVII Regulation by the CoA‐independent transacylase in human neutrophils
77. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
78. Biosynthesis of platelet‐activating factor. VI. Precursor of platelet‐activating factor and acetyltransferase activity in isolated rat kidney cells
79. Human endothelial cells in culture produce platelet‐activating factor (1‐al‐kyl‐2‐acetyl‐sn ‐glycerol‐3‐phosphocholine) when stimulated with trombin
80. Platelet‐activating factor
81. Evidence that biosynthesis of platelet‐activating factor (PAF‐acether) by human neutrophils occurs in an intracellular membrane
82. Subcellular localization of enzyme related to PAF metabolism in krebs‐II escite cells: evidence for the lack of intracellular transfer activity
83. Signal transduction during platelet‐activating factor‐induced lymphocyte binding to endothelial cells
84. Biosynthesis of l‐O‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine (platelet activating factor and a hypothensive lipid) by cholinephosphotransferase in various tissues
85. Topography of platelet activating factor metabolism in various cells models
86. Acylation of lysophos‐pholipids by rabbit alveolar macrophages. Specificities of CoA‐de‐pendent and CoA‐independent reactions
87. Platelet activating factor effects on endothelial cells
88. Development of a high‐performance liquid chro‐matographic‐mass spectrometry technique, with an ionspray interface, for the determination of platelet‐activating factor (PAF) and lyso‐PAF in biological samples
89. Platelet activating factor‐induced endothelial cells expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis
90. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistepparadigm
91. Platelet activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells
92. Stimulation of PAF‐synthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha‐toxin
93. 15‐Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine‐activated endothelia
94. Metabolism of platelet ativating factor (1‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue
95. Stimulated neutrophils produce ethanolamine plasmalogen analog of platelet‐activating factor
96. Regulation of platelet activating factor synthesis by acetyl Coenzyme A
97. Inhibition of the synthesis of platelet activating factor by anti‐inflammatory peptides (antiflammins) without methionine
98. Novel molecular anaogues of phosphatidylcholines in a lipid extract from bovine brain: 1‐long‐chain acyl‐2‐short‐chain acyl‐sn ‐glycero‐3‐phoshocholines
99. Differential synthesis of l‐acyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocho‐line by human inflammatory cells
100. Metabolism of l‐acyl‐2‐acetyl‐sn ‐glycero‐3‐phoSphocholine in the human neutrophils
101. Outer‐membrane porins from gram‐negative bacteria stimulate platelet‐activating‐factor biosynthesis by cultured human endothelial cells
102. A CoA‐independent transacylase is linked to the formation of PAF by generating lyso‐PAF intermediate in the remodeling pathway
103. Conversion of alkylacetyl‐glycerol to platelet activating factor in HL‐60 cells and subcellular localization of the mediator
104. Biphasic platelet‐activating factor synthesis by human monocytes stimulated with IL‐1‐β, tumor necrosis factor, or IFN‐γ
105. 3H]alkyl‐AA‐GroPCho to lyso‐PAF by the CoA‐independent transacylase in membrane fractions of neutrophils
106. Rickettsia stimulation of endothelial platelet‐activating factor synthesis
107. Production of platelet‐activating factor by endothelial cells
108. The regulation of platelet activating factor production in endothelial cells. The role of calcium and protein kinase C
109. Synthesis of platelet‐activating factor by endothelial cells. The role of G proteins
110. Relative amounts of 1‐O‐alkyI‐ and l‐acyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine in stimulated endothelial cells
111. Enzymic synthesis of 1‐alkyl‐2‐acetyl‐sn ‐glycero‐3‐phosphocholine, a hypotensive and platelet aggregating lipid
112. Characterisation of a human cDNA that encodes a functional receptor for platelet activating factor
113. Enhancement of Thrombin‐ and ionomycin‐stimulated prostacyclin and platelet‐activating factor production in cultured endothelial cells by a tumor‐promoting phorbol ester
114. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro
115. Endothelial cell‐associated platelet‐activating factor: a novel mechanism for signaling intercellular adhesion
116. Molecular determinants of lipid mediator‐induced leukocyte adherence and emigration in rat mesenteric venules